The Research Institute at Nationwide Children's Hospital is one of America's ten largest free-standing pediatric research centers and works to enhance the health of children by engaging in research.

Debiopharm International SA operates as a biopharmaceutical development company with focus on biologics and drug evaluation, licensing and development. It formulates and develops products for the treatment of cancer, endometriosis, uterine fibroids and hepatitis. The company was founded in 1979 and is headquartered in Lausanne, Switzerland.

The University of Iowa Research Foundation (UIRF) - a 501C3 corporation - commercializes University of Iowa developed technologies and inventions through licensing and new venture formation, and manages the subsequent revenue stream.

Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France.

Massachusetts General Hospital was established to provide care to Boston's sick, regardless of socioeconomic status—an innovative idea in 1811. In the words of their founder, John Warren, MD, “When in distress, every man becomes their neighbor.” They subsequently became the first teaching hospital for Harvard University’s new medical school and have been redefining excellence in healthcare ever since. They have remained at the forefront of medicine by fostering a culture of collaboration, pushing the boundaries of medical research, educating the brightest medical minds and maintaining an unwavering commitment to the diverse community they were created to serve. They believe that because of diversity they excel, through inclusion they respect their community, and with a keen focus on equity they serve, heal, educate and innovate at the highest levels. Their first priority is the well-being of their patients—near and far. As a team they are able to maintain a singular focus on providing the highest quality, most compassionate care to each and every patient.

IPA is a biotherapeutic research and technology company that leverages systems biology, multi-omics modeling, and complex artificial intelligence systems to support its proprietary technologies in bioplatform-based antibody discovery. Recently, IPA was ranked by one of the pharmaceutical industry’s most trusted and independent market research sources as having the highest competitive score for its antibody service portfolio.1 The company represents a HUB of biotherapeutic intelligence that includes a hybrid of experts and technologies, providing highly specialized full-continuum therapeutic antibody discovery and development —with advanced omics and complex artificial intelligence technology [LENSai] that provide greater efficiency and accuracy than ever before.  Our mission is to provide a HUB of the most advanced intelligence and technology to treat disease, bar none. Our goal is to support the advancement of novel biologics against even the most challenging targets, ultimately contributing to the treatment of diseases and the betterment of humankind. Footnote: 1. ROOTS 2022: Antibody Discovery Services and Platforms Market

Shijiazhuang Huada Medical Laboratory Co., Ltd., established on 2018-11-27, The scope of business includes medical laboratory:clinical immunization,Serology major,Clinical Cytomolecular Genetics Major;Engaged in technology development in the field of biotechnology,technical consulting,Technical Services,technology transfer,medical instruments,Laboratory equipment,Sales of computer software, hardware and auxiliary equipment;Realtor,Machinery and Equipment Leasing;Self-operated and agent import and export business of various commodities and technologies,Except for national restrictions and prohibitions.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Latvian Biomedical Research and Study centre (BMC) is the scientific institute in molecular biology and biomedicine in Latvia. Since its establishment in 1993 it has evolved into a scientific centre performing basic as well as applied research in molecular genetics, vaccine development, genomics and proteomics, cancer biology, immunology, biotechnology, stem cell biology, structure biology and other scientific areas.

IXYS Corporation a Silicon Valley power semiconductor company, has been developing technology-driven products to improve power conversion efficiency. IXYS is a pioneer in the development of power semiconductors that effectively monitor electrical voltage to produce maximum effect with least expenditure of energy. Through its nine divisions, IXYS offers products and technologies that span the entire power spectrum, addressing more than 90% of the overall power market.

BGI Genomics Co., Ltd. is a holding company that engages in development of science and technology services in genomics field. Its business scope ranges from scientific, health, agricultural and informatics. The company was founded by Wang Jian on September 9, 1999 and is headquartered in Shenzhen, China.

Regeneron Pharmaceuticals is a biopharmaceutical company that discovers, develops, and commercializes pharmaceutical products for the treatment of serious medical conditions. The Company has therapeutic candidates in clinical trials for the potential treatment of cancer, eye diseases, and inflammatory diseases, and has preclinical programs in other diseases and disorders. The company’s product portfolio includes EYLEA, an aflibercept injection; ARCALYST, a rilonacept Injection for subcutaneous use; ZALTRAP for metastatic colorectal cancer; trap fusion proteins; and fully human monoclonal antibodies. On March 26, 2012, it was announced that Sanofi and Regeneron are in development with a new cholesterol drug which will help reduce cholesterol up to 72%. Regeneron Pharmaceuticals was founded in 1988 and is currently headquartered in New York, USA.

Mor Research Applications is the Technology Transfer Office of Clalit Health Services, the largest HMO in Israel, providing end-to-end technology transfer services. MOR helps inventors translate new ideas in the medical, pharmaceutical, diagnostics, medical IT, and biotechnology areas into products and solutions that benefit healthcare providers and patients.